nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2011 |
39 |
6 |
p. IFC- 1 p. |
artikel |
2 |
A non-innovator version of etanercept for treatment of arthritis
|
Maity, Sunit |
|
2011 |
39 |
6 |
p. 384-395 12 p. |
artikel |
3 |
Antigen content versus volume of rabies vaccines administered intradermally
|
Dodet, B. |
|
2011 |
39 |
6 |
p. 444-445 2 p. |
artikel |
4 |
Collaborative study for the calibration of a replacement International Standard for Tetanus Toxoid Adsorbed
|
Tierney, Rob |
|
2011 |
39 |
6 |
p. 404-416 13 p. |
artikel |
5 |
Comparative efficacy of live replicating sheeppox vaccine strains in Ovines
|
Yogisharadhya, R. |
|
2011 |
39 |
6 |
p. 417-423 7 p. |
artikel |
6 |
Effectiveness of mouse minute virus inactivation by high temperature short time treatment technology: A statistical assessment
|
Murphy, Marie |
|
2011 |
39 |
6 |
p. 438-443 6 p. |
artikel |
7 |
Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products
|
Marcus-Sekura, Carol |
|
2011 |
39 |
6 |
p. 359-369 11 p. |
artikel |
8 |
Gamma irradiation of animal sera for inactivation of viruses and mollicutes – A review
|
Nims, Raymond W. |
|
2011 |
39 |
6 |
p. 370-377 8 p. |
artikel |
9 |
Glycan analysis of glycoprotein pharmaceuticals: Evaluation of analytical approaches to Z number determination in pharmaceutical erythropoietin products
|
Yuen, Chun-Ting |
|
2011 |
39 |
6 |
p. 396-403 8 p. |
artikel |
10 |
Investigation of xenotropic murine leukemia virus-related virus (XMRV) in human and other cell lines
|
Williams, Dhanya K. |
|
2011 |
39 |
6 |
p. 378-383 6 p. |
artikel |
11 |
Save the Date
|
|
|
2011 |
39 |
6 |
p. 446- 1 p. |
artikel |
12 |
Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus × O. aureus) with an inactivated Vibrio vulnificus vaccine
|
Shoemaker, Craig A. |
|
2011 |
39 |
6 |
p. 424-429 6 p. |
artikel |
13 |
Validation of model virus removal and inactivation capacity of an erythropoietin purification process
|
Pérez, Mayté |
|
2011 |
39 |
6 |
p. 430-437 8 p. |
artikel |